Investor Pitches for Technical Founders
Written by biotech investors themselves. The hook, the team, the need, the approach, the competition. Five essentials every life science founder needs to nail before walking into a funding conversation.
Most biotech pitch decks fail because founders optimize for scientific accuracy instead of investor clarity. This breaks down what a compelling biotech deck actually needs and what commonly derails them.
Scientific jargon, convoluted slide design, and missing strategic narrative. These are the three fastest ways to lose a biotech investor. A clear breakdown of the most common pitch failures and how to fix them.
From a VC firm that reviews hundreds of decks. The six slides that actually move biotech investors from curious to committed, and what founders consistently get wrong on each one.
Story-driven sequencing, risk transparency, and investor-aligned framing. Three things most biotech founders skip that make the difference between a forgettable deck and one that closes a round.
The most forgettable pitches are technically correct but narratively dead. This covers how to build a pitch that tells a story investors can follow, from the one-sentence pitch all the way through the full deck.
Investors decide within the first 30 seconds whether they are interested. Clarity, a compelling hook, and confident delivery are not optional extras. They are the pitch.
Real decks from funded biotech startups, broken down slide by slide. What they did right, where they stumbled, and what technical founders can learn from each one.